Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![ActuateThera Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1885029946894020608.png) Actuate Therapeutics [@ActuateThera](/creator/twitter/ActuateThera) on x XX followers
Created: 2025-07-18 16:45:14 UTC

“We are highly encouraged by the responses observed in refractory and resistant Ewing Sarcoma , a disease where treatment options are extremely limited beyond frontline chemotherapy,” said Daniel Schmitt, President & CEO of Actuate. Learn more: $ACTU

![](https://pbs.twimg.com/media/GwJ398GWIAgXdXc.jpg)

XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1946249916910543306/c:line.svg)

**Related Topics**
[$actu](/topic/$actu)
[$fro](/topic/$fro)

[Post Link](https://x.com/ActuateThera/status/1946249916910543306)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

ActuateThera Avatar Actuate Therapeutics @ActuateThera on x XX followers Created: 2025-07-18 16:45:14 UTC

“We are highly encouraged by the responses observed in refractory and resistant Ewing Sarcoma , a disease where treatment options are extremely limited beyond frontline chemotherapy,” said Daniel Schmitt, President & CEO of Actuate. Learn more: $ACTU

XXX engagements

Engagements Line Chart

Related Topics $actu $fro

Post Link

post/tweet::1946249916910543306
/post/tweet::1946249916910543306